Associate Professor David Whiley
Associate Professor

David Whiley

Email: 
Phone: 
+61 7 334 65053

Availability

Associate Professor David Whiley is:
Available for supervision

Fields of research

Clinical sciences Medical microbiology

Qualifications

  • Bachelor of Applied Science, Queensland University of Technology
  • Bachelor of Law, Queensland University of Technology
  • Postgraduate Diploma, Queensland University of Technology
  • Doctor of Philosophy, The University of Queensland

Search Professor David Whiley’s works on UQ eSpace

326 works between 2001 and 2025
All (326) Journal Article (283) Book Chapter (12) Conference Publication (30) Other Outputs (1)

1 - 20 of 326 works

2025

Journal Article

A rapid molecular detection tool for toxigenic M1UK Streptococcus pyogenes

Brouwer, Stephan, Das, Swairindhree, Hayes, Andrew J., Bertolla, Olivia M., Davies, Mark R., Walker, Mark J., Whiley, David M., Irwin, Adam D. and Tickner, Jacob A. (2025). A rapid molecular detection tool for toxigenic M1UK Streptococcus pyogenes. The Journal of Infectious Diseases, 231 (2), e375-e384. doi: 10.1093/infdis/jiae437

A rapid molecular detection tool for toxigenic M1UK Streptococcus pyogenes

2025

Journal Article

A perplexing diagnosis: role of real-time PCR for diagnosis of Haycocknema perplexum

Davidson, Natalie, Lowry, Kym, Parmar, Bijendrasinh Vikramsinh, Robertson, Thomas, Gupta, Rita, Harris, Patrick and Whiley, David (2025). A perplexing diagnosis: role of real-time PCR for diagnosis of Haycocknema perplexum. Pathology, 57, S92. doi: 10.1016/j.pathol.2024.12.378

A perplexing diagnosis: role of real-time PCR for diagnosis of Haycocknema perplexum

2024

Journal Article

A novel murine model mimicking male genital Neisseria species infection using Neisseria musculi

Bryan, Emily R., McRae, Julia, Kumar, Vishnu, Trim, Logan K, Maidment, Toby I, Tickner, Jacob A D, Sweeney, Emma L, William, Elizabeth D, Whiley, David M and Beagley, Kenneth W (2024). A novel murine model mimicking male genital Neisseria species infection using Neisseria musculi. Biology of Reproduction, 111 (3), 613-624. doi: 10.1093/biolre/ioae100

A novel murine model mimicking male genital Neisseria species infection using Neisseria musculi

2024

Journal Article

Emergence of an extensively drug-resistant Neisseria gonorrhoeae clone

van Hal, Sebastiaan J., Sherry, Norelle, Coombs, Geoff, Mowlaboccus, Shakeel, Whiley, David M. and Lahra, Monica M. (2024). Emergence of an extensively drug-resistant Neisseria gonorrhoeae clone. The Lancet Infectious Diseases, 24 (9), e547-e548. doi: 10.1016/s1473-3099(24)00486-9

Emergence of an extensively drug-resistant Neisseria gonorrhoeae clone

2024

Journal Article

Clinical effectiveness and analytical quality of a national point-of-care testing network for sexually transmitted infections integrated into rural and remote primary care clinics in Australia, 2016–2022: an observational program evaluation

Causer, Louise M., Ward, James (TTANGO2 Collaboration), Smith, Kirsty, Saha, Amit, Andrewartha, Kelly, Wand, Handan, Hengel, Belinda, Badman, Steven G., Tangey, Annie, Matthews, Susan, Mak, Donna, Gunathilake, Manoji, Moore, Elizabeth, Speers, David, Persing, David, Anderson, David, Whiley, David (TTANGO2 Collaboration), Maher, Lisa, Regan, David, Donovan, Basil, Fairley, Christopher, Kaldor, John, Shephard, Mark, Guy, Rebecca and TTANGO2 Collaboration (2024). Clinical effectiveness and analytical quality of a national point-of-care testing network for sexually transmitted infections integrated into rural and remote primary care clinics in Australia, 2016–2022: an observational program evaluation. The Lancet Regional Health - Western Pacific, 48 101110, 1-12. doi: 10.1016/j.lanwpc.2024.101110

Clinical effectiveness and analytical quality of a national point-of-care testing network for sexually transmitted infections integrated into rural and remote primary care clinics in Australia, 2016–2022: an observational program evaluation

2024

Journal Article

Ceftriaxone resistance in Neisseria gonorrhoeae associated with the penA-60.001 allele in Hanoi, Viet Nam

Adamson, Paul C., Hieu, Vu N., Nhung, Pham H., Whiley, D. M. and Chau, T. M. (2024). Ceftriaxone resistance in Neisseria gonorrhoeae associated with the penA-60.001 allele in Hanoi, Viet Nam. The Lancet Infectious Diseases, 24 (6), e351-e352. doi: 10.1016/s1473-3099(24)00230-5

Ceftriaxone resistance in Neisseria gonorrhoeae associated with the penA-60.001 allele in Hanoi, Viet Nam

2024

Journal Article

Sustained transmission over two decades of a previously unrecognised MPT64 negative Mycobacterium tuberculosis strain in Queensland, Australia: a whole genome sequencing study

Bainomugisa, Arnold, Pandey, Sushil, O'Connor, Bridget, Syrmis, Melanie, Whiley, David, Sintchenko, Vitali, Coin, Lachlan J.M., Marais, Ben J. and Coulter, Christopher (2024). Sustained transmission over two decades of a previously unrecognised MPT64 negative Mycobacterium tuberculosis strain in Queensland, Australia: a whole genome sequencing study. The Lancet Regional Health - Western Pacific, 47 101105, 1-12. doi: 10.1016/j.lanwpc.2024.101105

Sustained transmission over two decades of a previously unrecognised MPT64 negative Mycobacterium tuberculosis strain in Queensland, Australia: a whole genome sequencing study

2024

Journal Article

The AMR Hub: a public–private partnership to overcome barriers to commercialisation and deliver antimicrobial stewardship innovations

Bonello, Michelle, Applegate, Tanya L., Badman, Steve, Bradshaw, Catriona S., Broom, Alex, Field, Paul, Hocking, Jane S., Huston, Wilhelmina M., Kong, Fabian, Murray, Gerald L., Mokany, Elisa, Pasricha, Shivani, Todd, Alison V., Whiley, David M., Wiseman, Virginia and Guy, Rebecca (2024). The AMR Hub: a public–private partnership to overcome barriers to commercialisation and deliver antimicrobial stewardship innovations. Microbiology Australia, 45 (2), 48-53. doi: 10.1071/MA24017

The AMR Hub: a public–private partnership to overcome barriers to commercialisation and deliver antimicrobial stewardship innovations

2024

Journal Article

Comprehensive observational study evaluating the enduring effectiveness of 4CMenB, the meningococcal B vaccine against gonococcal infections in the Northern Territory and South Australia, Australia: study protocol

Marshall, Helen, Ward, James, Wang, Bing, Andraweera, Prabha, McMillan, Mark, Flood, Louise, Bell, Charlotte, Sisnowski, Jana, Krause, Vicki, Webby, Rosalind, Childs, Emma, Gunathilake, Manoji, Egoroff, Natasha, Leong, Lex, Lawrence, Andrew, Baird, Rob, Freeman, Kevin, Menouhos, Dimitrios, Whiley, David M, Karnon, Jonathan, van Hal, Sebastian and Lahra, Monica M (2024). Comprehensive observational study evaluating the enduring effectiveness of 4CMenB, the meningococcal B vaccine against gonococcal infections in the Northern Territory and South Australia, Australia: study protocol. BMJ Open, 14 (5) e079144, 1-8. doi: 10.1136/bmjopen-2023-079144

Comprehensive observational study evaluating the enduring effectiveness of 4CMenB, the meningococcal B vaccine against gonococcal infections in the Northern Territory and South Australia, Australia: study protocol

2024

Journal Article

Correction: Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis

Chai, Ming G., Tu, Quyen, Cotta, Menino O., Bauer, Michelle J., Balch, Ross, Okafor, Charles, Comans, Tracy, Kruger, Peter, Meyer, Jason, Shekar, Kiran, Brady, Kara, Fourie, Cheryl, Sharp, Natalie, Vlad, Luminita, Whiley, David, Ungerer, Jacobus P. J., Mcwhinney, Brett C., Farkas, Andras, Paterson, David L., Clark, Julia E., Hajkowicz, Krispin, Raman, Sainath, Bialasiewicz, Seweryn, Lipman, Jeffrey, Forde, Brian M., Harris, Patrick N. A., Schlapbach, Luregn J., Coin, Lachlan, Roberts, Jason A. and Irwin, Adam D. (2024). Correction: Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis. Intensive Care Medicine, 50 (5), 810-810. doi: 10.1007/s00134-024-07393-9

Correction: Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis

2024

Journal Article

Multicentre double-blind randomised placebo-controlled trial evaluating the efficacy of the meningococcal B vaccine, 4CMenB (Bexsero), against Neisseria gonorrhoeae infection in men who have sex with men: the GoGoVax study protocol

Seib, Kate L., Donovan, Basil, Thng, Caroline, Lewis, David A., McNulty, Anna, Fairley, Christopher K., Yeung, Barbara, Jin, Fengyi, Fraser, Doug, Bavinton, Benjamin R., Law, Matthew, Chen, Marcus Y., Chow, Eric P. F., Whiley, David M., Mackie, Brent, Jennings, Michael P., Jennison, Amy V., Lahra, Monica M. and Grulich, Andrew E. (2024). Multicentre double-blind randomised placebo-controlled trial evaluating the efficacy of the meningococcal B vaccine, 4CMenB (Bexsero), against Neisseria gonorrhoeae infection in men who have sex with men: the GoGoVax study protocol. BMJ Open, 14 (4) e081675, 1-9. doi: 10.1136/bmjopen-2023-081675

Multicentre double-blind randomised placebo-controlled trial evaluating the efficacy of the meningococcal B vaccine, 4CMenB (Bexsero), against Neisseria gonorrhoeae infection in men who have sex with men: the GoGoVax study protocol

2024

Journal Article

Response to the ASHM 2023 statement on the use of doxy-PEP in Australia: considerations and recommendations

Bell, Sara F. E., Sweeney, Emma L., Kong, Fabian Y. S., Whiley, David M., Bradshaw, Catriona S. and Tickner, Jacob A. (2024). Response to the ASHM 2023 statement on the use of doxy-PEP in Australia: considerations and recommendations. Medical Journal of Australia, 220 (7), 356-360. doi: 10.5694/mja2.52255

Response to the ASHM 2023 statement on the use of doxy-PEP in Australia: considerations and recommendations

2024

Journal Article

Point-of-care testing and treatment of sexually transmitted and genital infections to improve birth outcomes in high-burden, low-resource settings (WANTAIM): a pragmatic cluster randomised crossover trial in Papua New Guinea

Riddell, Michaela A., Vallely, Lisa M., Mengi, Alice, Badman, Steven G., Low, Nicola, Wand, Handan, Bolnga, John W., Babona, Delly, Mola, Glen D. L., Wiseman, Virginia, Kelly-Hanku, Angela, Homer, Caroline S. E., Morgan, Christopher, Luchters, Stanley, Whiley, David M., Robinson, Leanne J., Au, Lucy, Pukai-Gani, Irene, Laman, Moses, Kariwiga, Grace, Toliman, Pamela J., Batura, Neha, Tabrizi, Sepehr N., Rogerson, Stephen J., Garland, Suzanne M., Guy, Rebecca J., Peeling, Rosanna W., Pomat, William S., Kaldor, John M. and Vallely, Andrew J. B. (2024). Point-of-care testing and treatment of sexually transmitted and genital infections to improve birth outcomes in high-burden, low-resource settings (WANTAIM): a pragmatic cluster randomised crossover trial in Papua New Guinea. Lancet Global Health, 12 (4), e641-e651. doi: 10.1016/S2214-109X(24)00004-4

Point-of-care testing and treatment of sexually transmitted and genital infections to improve birth outcomes in high-burden, low-resource settings (WANTAIM): a pragmatic cluster randomised crossover trial in Papua New Guinea

2024

Journal Article

Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis

Chai, Gene G., Tu, Quyen, Cotta, Menino O., Bauer, Michelle J., Balch, Ross, Okafor, Charles, Comans, Tracy, Kruger, Peter, Meyer, Jason, Shekar, Kiran, Brady, Kara, Fourie, Cheryl, Sharp, Natalie, Vlad, Luminita, Whiley, David, Ungerer, Jacobus P. J., McWhinney, Brett C., Farkas, Andras, Paterson, David L., Clark, Julia E., Hajkowicz, Krispin, Raman, Sainath, Bialasiewicz, Seweryn, Lipman, Jeffrey, Forde, Brian M., Harris, Patrick N. A., Schlapbach, Luregn J., Coin, Lachlan, Roberts, Jason A. and Irwin, Adam D. (2024). Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis. Intensive Care Medicine, 50 (4), 1-9. doi: 10.1007/s00134-024-07353-3

Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis

2024

Journal Article

High prevalence of ceftriaxone-resistant and XDR Neisseria gonorrhoeae in several cities of Cambodia, 2022–23: WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP)

Ouk, V, Heng, L Say, Virak, M, Deng, S, Lahra, M M, Frankson, R, Kreisel, K, McDonald, R, Escher, M, Unemo, M, Wi, T, Maatouk, I, Penh, Phnom, Fensham, Vivian, Kersh, Ellen, Cavailler, Philippe, Mundade, Yamuna, Hal, Sebastiaan J van, Kundu, Ratan L, Hogan, Tiffany R, Whiley, David M, Izumi, Kiyohiko, Nishijima, Takeshi, EGASP Cambodia Working Group and Whiley, David (2024). High prevalence of ceftriaxone-resistant and XDR Neisseria gonorrhoeae in several cities of Cambodia, 2022–23: WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP). JAC-Antimicrobial Resistance, 6 (2) dlae053, 2. doi: 10.1093/jacamr/dlae053

High prevalence of ceftriaxone-resistant and XDR Neisseria gonorrhoeae in several cities of Cambodia, 2022–23: WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP)

2024

Journal Article

Comparison of nasopharyngeal swab vs. lower respiratory tract specimen PCR for the diagnosis of Pneumocystis jirovecii pneumonia

Chew, Rusheng, Tozer, Sarah, Ulett, Kimberly, Paterson, David L., Whiley, David, Sloots, Theo, Fielding, David, Zappala, Christopher, Bashirzadeh, Farzad, Hundloe, Justin, Bletchley, Cheryl and Woods, Marion L. (2024). Comparison of nasopharyngeal swab vs. lower respiratory tract specimen PCR for the diagnosis of Pneumocystis jirovecii pneumonia. Open Forum Infectious Diseases, 11 (3) ofae071, ofae071. doi: 10.1093/ofid/ofae071

Comparison of nasopharyngeal swab vs. lower respiratory tract specimen PCR for the diagnosis of Pneumocystis jirovecii pneumonia

2024

Journal Article

Concurrent parC and gyrA fluoroquinolone resistance mutations and associated strains in Mycoplasma genitalium in Queensland, Australia

Ertl, Nicole G., Anderson, Taylah K., Pardo, Carolyn J., Maidment, Toby I., Murray, Gerald L., Bradshaw, Catriona S., Whiley, David M. and Sweeney, Emma L. (2024). Concurrent parC and gyrA fluoroquinolone resistance mutations and associated strains in Mycoplasma genitalium in Queensland, Australia. Journal of Antimicrobial Chemotherapy, 79 (2), 467-469. doi: 10.1093/jac/dkad373

Concurrent parC and gyrA fluoroquinolone resistance mutations and associated strains in Mycoplasma genitalium in Queensland, Australia

2024

Journal Article

Investigating oral human papillomavirus co-infection with Neisseria gonorrhoeae and Chlamydia trachomatis

Trembizki, Ella, Anderson, Taylah, Whiley, David M. and Antonsson, Annika (2024). Investigating oral human papillomavirus co-infection with Neisseria gonorrhoeae and Chlamydia trachomatis. Epidemiology and Infection, 152 e8, e8. doi: 10.1017/s095026882300198x

Investigating oral human papillomavirus co-infection with Neisseria gonorrhoeae and Chlamydia trachomatis

2024

Conference Publication

Simplifying approaches to detect Mycoplasma genitalium parC resistance mutations, to facilitate individualised fluoroquinolone treatment

Sweeney, Emma L., Bradshaw, Catriona, Murray, Gerald, Tickner, Jacob A. and Whiley, David (2024). Simplifying approaches to detect Mycoplasma genitalium parC resistance mutations, to facilitate individualised fluoroquinolone treatment. Annual Meeting of the Infectious-Diseases-Society-for-Obstetrics-and-Gynecology (IDSOG), Boston, MA, United States, 4-6 August 2022. Philadelphia, PA, United States: Lippincott Williams & Wilkins.

Simplifying approaches to detect Mycoplasma genitalium parC resistance mutations, to facilitate individualised fluoroquinolone treatment

2024

Conference Publication

gyrA Mutations in Mycoplasma Genitalium Contribute to Moxifloxacin Failure - A New Target For Resistance-guided Therapy

Murray, Gerald, Plummer, Erica L., Bodihabadu, Kaveesha, Torres, Jose, Chua, Teck-Phui, Machalek, Dorothy, Garland, Suzanne M., Doyle, Michelle, Sweeney, Emma L., Whiley, David and Bradshaw, Catriona (2024). gyrA Mutations in Mycoplasma Genitalium Contribute to Moxifloxacin Failure - A New Target For Resistance-guided Therapy. Annual Meeting of the Infectious-Diseases-Society-for-Obstetrics-and-Gynecology (IDSOG), Boston, MA, United States, 4-6 August 2022. Philadelphia, PA, United States: Lippincott Williams & Wilkins.

gyrA Mutations in Mycoplasma Genitalium Contribute to Moxifloxacin Failure - A New Target For Resistance-guided Therapy

Current funding

  • 2024 - 2026
    Rapid detection of Neisseria gonorrhoeae and relevant antimicrobial resistance targets
    Bill & Melinda Gates Foundation
    Open grant
  • 2024 - 2025
    A Rapid, Routine Genomics Service for Clinical Haematology (QLD Health Targeted CRF led by RBWH Metro North Health)
    Metro North Hospital and Health Service
    Open grant
  • 2023 - 2027
    Accelerating pathogen detection and antibiotic resistance prediction in children with suspected sepsis
    The Children's Hospital Foundation
    Open grant
  • 2022 - 2025
    Tackling the rise: Expanded gonorrhoea screening to inform guidelines for asymptomatic heterosexual women and men
    Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine
    Open grant
  • 2022 - 2027
    Scaling up infectious disease point-of-care testing for Indigenous people (MRFF Rapid Applied Research Translation Grant administered by UNSW)
    University of New South Wales
    Open grant
  • 2021 - 2026
    ARC Research Hub to Combat Antimicrobial Resistance (ITRH led by University of New South Wales)
    University of New South Wales
    Open grant
  • 2021 - 2025
    META-GP: Delivering a Clinical Metagenomics Platform for Australia (administered by University of Melbourne)
    University of Melbourne
    Open grant
  • 2020 - 2025
    Eliminating endemic sexually transmissible infections in remote Australia using targeted multidisciplinary strategies
    NHMRC Synergy Grants
    Open grant

Past funding

  • 2022
    ResistancePlus MABSC/MAC test for detection of MABSC, MAC and gene markers associated with susceptibility or resistance to macrolides and amikacin antibiotics
    SpeedX
    Open grant
  • 2021 - 2022
    Improving Diagnosis, Management and Prevention of Invasive Meningococcal Disease
    Metro North Hospital and Health Service
    Open grant
  • 2020 - 2023
    The development of an integrated molecular diagnostic pathway to optimise the treatment of cytomegalovirus in children undergoing haematopoietic stem cell transplant
    The Children's Hospital Foundation
    Open grant
  • 2020 - 2024
    Precision public health and precision medicine for enhanced management sexually transmitted infections in Queensland
    Queensland Advancing Clinical Research Fellowship
    Open grant
  • 2020
    Refining a method for Effective Pooling of Anatomical Specimens for the Detection of STI RAPID GeneXpert CT/NG Pooling Trial
    Cepheid
    Open grant
  • 2020 - 2024
    A multicentre randomised controlled trial evaluating the efficacy of the meningococcal B vaccine, 4CMenB (Bexsero), against Neisseria gonorrhoeae... (NHMRC CTCS administered by Griffith University)
    Griffith University
    Open grant
  • 2019 - 2024
    Gono B Gone: Targeted immunisation programs for vulnerable children and young people against serious infectious diseases (NHMRC Partnership Project administered by University of Adelaide)
    University of Adelaide
    Open grant
  • 2019 - 2022
    Precision public health for enhanced syphilis management in Queensland
    Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine
    Open grant
  • 2019 - 2021
    Optimizing antimicrobial therapy for urinary tract infections in children via rapid direct next generation sequencing
    Pathology Queensland - Study, Education & Research Trust Fund
    Open grant
  • 2019 - 2021
    Virulence and detection of Escherichia coli that cause neonatal meningitis
    The Children's Hospital Foundation
    Open grant
  • 2018 - 2025
    Centre for Research Excellence in the accelerated implementation of new point-of-care technology for infectious diseases (NHMRC CRE Grant administered by the University of New South Wales)
    University of New South Wales
    Open grant
  • 2018 - 2020
    Enhanced diagnostic testing for Mycoplasma genitalium antibiotic resistance
    Pathology Queensland - Study, Education & Research Trust Fund
    Open grant
  • 2018 - 2019
    Sakzewski Core Translational Research Group
    The Children's Hospital Foundation
    Open grant
  • 2018 - 2021
    Enhancing detection and management of Mycobacterium abscessus complex (MABSC) infection in children with cystic fibrosis
    The Children's Hospital Foundation
    Open grant
  • 2018
    Individualised treatment of bacterial infections via rapid molecular detection of antibiotic resistant superbugs
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018 - 2021
    Modelling the impact of strategies to control gonorrhoea and minimise the threat of antimicrobial resistance in remote Indigenous and (NHMRC Project Grant led by the University of New South Wales)
    University of New South Wales
    Open grant
  • 2017 - 2019
    An enhanced diagnostic test for Rotavirus infection
    Pathology Queensland - Study, Education & Research Trust Fund
    Open grant
  • 2017 - 2019
    A randomised controlled trial of daily antibacterial mouthwash to reduce pharyngeal gonorrhoea among men who have sex with men (MSM) (NHMRC Project Grant led by Monash University)
    Monash University
    Open grant
  • 2017 - 2021
    Use of molecular resistance assays to provide alterative oral treatment strategies for gonorrhoea in Indigenous and other high-risk populations; a randomised cluster trial
    NHMRC Project Grant
    Open grant
  • 2016 - 2017
    Typing isolates of Neisseria gonorrhoea
    Cempra Pharmaceuticals, Inc.
    Open grant
  • 2016 - 2020
    Resistance PCR collaborative project
    SpeedX
    Open grant
  • 2016 - 2019
    Gonorrhoea: detection, antimicrobial resistance and treatment.
    NHMRC Career Development Fellowship
    Open grant
  • 2015
    Combating the new antimicrobial resistance threat: development and implementation of cost-effective molecular surveillance tools
    Pathology Queensland - Study, Education & Research Trust Fund
    Open grant
  • 2015 - 2016
    New molecular tools to identify groups of individuals at increased risk of human immunodeficiency virus (HIV) acquisition
    HIVFQ HIV Research Grants
    Open grant
  • 2014 - 2015
    Ending trachoma: chasing Chlamydia trachomatis in eyes and from Australia
    Queensland University of Technology
    Open grant
  • 2014 - 2016
    Intra-strain diversity of Pseudomonas aeruginosa in the lungs of patients with CF and their role in exacerbation
    Prince Charles Hospital Foundation
    Open grant
  • 2014 - 2018
    New ways to increase the number of people in remote Aboriginal communities tested for sexually transmitted infections (NHMRC Project Grant administered by UNSW)
    University of New South Wales
    Open grant
  • 2013 - 2015
    NHMRC ECF (Health Prof RF (PT) - Public Health): Acquisition and transmission of respiratory pathogens in persons with cystic fibrosis (CF): development and implementation of novel molecular tools
    NHMRC Training (Postdoctoral) Fellowship
    Open grant
  • 2012 - 2015
    Molecular surveillance methods for Neisseria gonorrhoeae antimicrobial resistance
    Royal Children's Hospital Foundation
    Open grant
  • 2012 - 2015
    Neisseria gonorrhoeae antimicrobial resistance: detection and propagation
    NHMRC Project Grant
    Open grant
  • 2011 - 2014
    A randomised trial of rapid point-of-care tests for chlamydia and gonorrhoea infections in remote Aboriginal communities (NHMRC Project Grant administered by UNSW)
    University of New South Wales
    Open grant
  • 2011
    Metagenomic analysis of bronchoalveolar lavage fluid from children with cystic fibrosis and disease controls
    Royal Children's Hospital Foundation
    Open grant
  • 2011 - 2014
    The genetic properties of clonal Pseudomonas Aeruginosa strains in Brisbane patients with CF
    Royal Children's Hospital Foundation
    Open grant
  • 2010 - 2011
    Development of a novel assay for the detection of clonal P.aeruginosa in persons with CF
    Australian Cystic Fibrosis Research Trust
    Open grant
  • 2010 - 2014
    Burden of respiratory infection in the first 2 years of life: a birth cohort study of emerging respiratory pathogens
    NHMRC Project Grant
    Open grant
  • 2009 - 2011
    Identification of unknown viruses causing respiratory disease in children
    Royal Children's Hospital Foundation
    Open grant

Availability

Associate Professor David Whiley is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    New treatment strategies for STIs: Development of a molecular diagnostic test for cefixime-resistant gonorrhoea

    Principal Advisor

    Other advisors: Dr Emma Sweeney

  • Doctor Philosophy

    The epidemiology of gonorrhoea in Queensland

    Principal Advisor

    Other advisors: Associate Professor Steve Lambert

  • Doctor Philosophy

    Rapid detection of AMR targets using isothermal technology.

    Principal Advisor

    Other advisors: Associate Professor Adam Irwin

  • Doctor Philosophy

    Rapid detection of AMR targets using isothermal technology

    Principal Advisor

    Other advisors: Associate Professor Adam Irwin

  • Doctor Philosophy

    Rapid detection of AMR targets using isothermal technology

    Principal Advisor

    Other advisors: Associate Professor Adam Irwin

  • Doctor Philosophy

    Design and evaluation of point-of-care molecular diagnostics and metagenomics for tropical aetiological surveillence.

    Principal Advisor

  • Doctor Philosophy

    Design and evaluation of point-of-care molecular diagnostics and metagenomics for tropical aetiological surveillence.

    Principal Advisor

  • Doctor Philosophy

    The development of an integrated molecular diagnostic pathway to optimise the treatment of cytomegalovirus in children undergoing haematopoietic stem cell transplant

    Associate Advisor

    Other advisors: Dr Kym Lowry, Associate Professor Adam Irwin, Dr Emma Sweeney

  • Doctor Philosophy

    The development of an integrated molecular diagnostic pathway to optimise the treatment of cytomegalovirus in children undergoing haematopoietic stem cell transplant

    Associate Advisor

    Other advisors: Dr Kym Lowry, Associate Professor Adam Irwin, Dr Emma Sweeney

  • Doctor Philosophy

    Accelerating pathogen detection and antibiotic resistance prediction in children with suspected sepsis.

    Associate Advisor

    Other advisors: Dr Patrick Harris, Associate Professor Adam Irwin

Completed supervision

Enquiries

For media enquiries about Associate Professor David Whiley's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au